Alpha GPC: Difference between revisions

From GandG.cloud
Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated.
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated.


UPDATE: As of May 2026, it has passed the safety assessment by EFSA [Safety of L‐alpha‐glycerylphosphorylcholine (L‐alpha‐GPC) from soya phospholipids (lecithin) as a novel food pursuant to Regulation (EU) 2015/2283 - - 2026 - EFSA Journal - Wiley Online Library]
UPDATE: As of May 2026, it has passed the safety assessment by EFSA [https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2026.10008]





Revision as of 14:59, 19 May 2026

L-alpha-glycerylphosphorylcholine.

Commonly requested in sport and nootropic products. This is likely medicinal according to the HFMA.

UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated.

UPDATE: As of May 2026, it has passed the safety assessment by EFSA [1]